Blog

For Dying Matters Week (6-12 May) we have been sharing content around death and dying and the conversations we have – specifically between healthcare professionals, carers and our families. One of our supporters, Emily, shares with us her story of losing her mum and how hospice at home care was so important.

We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Lorna shares her story.

We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Sarah shares her story.

We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Helen shares her story.

We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Jess shares her story.

Pembrolizumab, also known as Keytruda®, is a drug used to treat a variety of cancers1. In breast cancer, Keytruda is currently used to treat both early and secondary triple negative breast cancer (TNBC).

We're sharing stories from some of our wonderful members of the community who have a diagnosis of Triple Negative. Lisa shares her story.

For #TripleNegativeBreastCancerDay (Sun 3 March, 2024) we are shining a light on some of our wonderful members of the community who have a diagnosis of Triple Negative. Mary shares her story.

For #TripleNegativeBreastCancerDay (Sun 3 March, 2024) we are shining a light on some of our wonderful members of the community who have a diagnosis of Triple Negative. Kathryn shares her story.

Next month sees the launch of one of our new fundraising challenges: Abseiling the Falkirk Wheel! Lianne from the Make 2nds Count Fundraising Team will be taking part in this epic challenge to raise money to help support secondary breast cancer patients.

We recently caught up with one of our ambassadors Marette, who's husband has signed up to take part in the London Marathon in April. We wanted to know a bit about Marette and why her husband has choose to fundraise for Make 2nds Count.

SBC & ME Date of Diagnosis: 13/04/2021 Current Treatment Line: Palbociclib, denosumab, zoladex, apixaban, letrozole How Does SBC Affect Your Life: The cancer is in my bones and I had a proximal femoral endoprosthetic replacement (replacement of hip socket and femur) walking is difficult and the distance is limited. I still work full time as it provides my normality and a distraction from the cancer world of hospital appointments and scans.

Aromatase inhibitors are a class of drugs that can be used to treat hormone receptor-positive (HR+) subtypes of breast cancer1. Aromatase inhibitors can be used in the treatment of early HR+ breast cancer, but here we will focus on aromatase inhibitors in treating secondary (metastatic, advanced) breast cancer.

Make 2nds Count have had an incredible year of fundraising in 2023. As we look back at some of the amazing fundraising events we would like to thank all our supporters for all events big and small and for making it the year that it was.

What a busy year it has been in Research! Since welcoming our new Research Manager, Dr Sarah Thomas, we have completed our first research grant awarded by the charity, announced our largest ever grant and launched our first open call for research proposals to kick off in 2024.